Causal Pathways Explained

• Causal pathways are formally defined subgraphs in directed acyclic graphs that map cause–effect sequences, enabling precise mediation and mechanistic inference.
• They leverage counterfactual theory, do-calculus, and machine learning to quantify and validate effects, with applications in genomics, epidemiology, neuroscience, and AI.
• Practical frameworks use DAG discovery, structural equation modeling, and stability selection to identify, estimate, and falsify pathway-specific contributions in complex systems.

A causal pathway is a formally defined sequence or subgraph of cause–effect relationships within a directed acyclic graph (DAG) or related structure, specifying the mechanisms through which an exposure, intervention, or disturbance exerts its effects on an outcome. The concept underpins mediation, mechanistic inference, multi-stage intervention design, and explanations of complex systems across scientific domains, including genomics, epidemiology, neuroscience, social science, and artificial intelligence. Modern research rigorously quantifies, estimates, and sometimes falsifies causal pathways using tools from counterfactual theory, structural equation modeling, information theory, and machine learning.

1. Formal Definition and Abstraction

Causal pathways are explicitly defined as specific subgraphs within a DAG equipped with probabilistic and (sometimes) interventional semantics.

• Formalization: A causal pathway is a tuple $(\mathcal{G},P,B=\{B_1,\dots,B_k\},B_t,B_R,P_B)$, with $\mathcal{G}$ a DAG over binary (or arbitrary) variables $B_j$, $P_B$ a joint distribution Markov with respect to $\mathcal{G}$, $B_R$ the root (cause) nodes, $B_t$ the target (sink) node, and $P$ the subgraph (pathway) connecting $B_R$ to $B_t$ (Haghighat et al., 29 May 2026).
• Interventional Semantics: The pathway specifies how the interventional probability $\mathcal{G}$0 relates to the probability of the event of interest. For rare events, pathway-explanation scores formalize when a candidate chain truly explains the occurrence of $\mathcal{G}$1 (Haghighat et al., 29 May 2026).
• Abstraction: High-dimensional SEMs can be abstracted to lower-dimensional binary pathways by defining features and thresholds over groups of nodes, preserving pathway-level interventional probabilities and explanation accuracy measured via KL-divergence (Haghighat et al., 29 May 2026).

2. Identification and Decomposition Principles

Identification of effects along pathways relies on modern counterfactual theory, do-calculus, and sequential mediation decomposition.

• Potential-Outcome Framework: For ordered mediators $\mathcal{G}$2, path-specific effects (PSEs) are defined as differences of nested counterfactual outcomes that vary some mediators while holding others fixed, e.g., $\mathcal{G}$3 (Kundu et al., 1 Jun 2026).
• Identification via Do-Calculus: Pathway effects can be identified (expressed in terms of observed data distributions) if the pathway satisfies the appropriate back-door, front-door, or more general criteria via do-calculus on the DAG or latent-variable graph (Mohammad-Taheri et al., 2021, Kundu et al., 1 Jun 2026).
• Decomposition: The total effect of an exposure is formally decomposed into direct, indirect, and sequential/specific pathway components using counterfactual definitions:

$\mathcal{G}$4

where $\mathcal{G}$5 and $\mathcal{G}$6 are natural direct and indirect effects through specific mediators, and $\mathcal{G}$7 is spurious residual (Kohankhaki et al., 2024, Kundu et al., 1 Jun 2026).

3. Methodological Approaches to Discovery and Estimation

Several frameworks have been developed for the practical discovery, estimation, and validation of causal pathways.

• Constraint- and Score-Based Structure Learning: Algorithms using BIC or conditional-independence tests search for DAGs consistent with observed data, retaining edges and nodes essential for plausible pathways (e.g., hill-climb algorithm with BIC, Monte Carlo validation) (Wei et al., 10 May 2025).
• Information-Theoretic Pathway Scoring: For stationary time series, the causality graph is inferred via conditional independence tests, and pathway-specific information transfer measures (e.g., MITP, MII) are computed to quantify the strength of information propagation along each causal route (Runge, 2015).
• Generalized Structural Equation Modeling (GSEM): Incorporation of structured latent confounders and multiple mediators enables identification and estimation of direct and indirect effects even when some confounders are unmeasured (Yuan et al., 2023).
• Machine Learning and High-Dimensional Mediation: Data-adaptive strategies such as NOVAPathways detect pathways within high-dimensional exposures and mediators by sequential semi-parametric regression and stochastic interventions, requiring only $\mathcal{G}$8-rate estimation of nuisance functions for $\mathcal{G}$9-consistency when exposures are quantized (McCoy et al., 2023).

Method/Class	Identification Basis	Estimation Principle
Do-calculus / SCM	Graphical rules + back/front door	Bayesian LVM, G-computation (Mohammad-Taheri et al., 2021)
GSEM (with surrogates)	Additive factor structure, proxies	Blockwise backfitting, ML (Yuan et al., 2023)
High-Dim Mediation	Basis expansion, cross-fitted EIF	One-step/TMLE, CV (McCoy et al., 2023)
Information Theory	Stationarity, conditional MI	PCMCI, path-specific CMI (Runge, 2015)

4. Causal Pathway Quantification and Falsification

Quantitative assessment of causal pathways involves both estimation of pathway-specific effects and hypothesis testing.

• Explanation Scores: For rare events, explanation scores such as $B_j$0 require that all pathway nodes contribute substantially to explanation, and pathway-only testability is established via explicit $B_j$1-value bounds (Haghighat et al., 29 May 2026).
• Sequential Mediation Inference: Composite nulls for sequentially ordered mediators (e.g., $B_j$2) require robust, studentized test statistics (SOMET) to avoid inflated type I error in the presence of nuisance orthogonality or degenerate variances (Kundu et al., 1 Jun 2026).
• Pathway Falsifiability: Weak or missing links in candidate pathways (e.g., low $B_j$3) are systematically rejected using monotonicity-bounded likelihoods, with direct implications for rare event root-cause analysis (Haghighat et al., 29 May 2026).

5. Domain-Specific Applications

Causal pathways are fundamental in diverse domains, each presenting unique methodological and substantive challenges.

• Genomics and Systems Biology: Multi-stage inference links genetic variation to risk factors and disease through metabolomic/omic networks, using instrumental variables and DAG learning (e.g., LRRC46→Urate→Triglycerides pathways) (Yazdani et al., 2018), group lasso for overlapping pathways (Silver et al., 2012), or dynamic embeddings in rare disease gene prioritization (Saadat et al., 2024).
• Social and Behavioral Science: Discovery of indirect effects from environmental or familial exposures to behavioral outcomes (e.g., parental substance use to child externalizing, with quantified direct and indirect paths) uses structural equation modeling and stability-verified DAGs (Wei et al., 10 May 2025).
• Neuroscience and Complex Systems: Measures such as path-based information transfer allow causal abstraction of high-dimensional dynamic processes (e.g., atmospheric/climate variables (Runge, 2015)).
• Artificial Intelligence and Deep Learning: Extraction of causal diffusion pathways within neural networks elucidates the routes by which input components affect outputs, with pathway ablation demonstrating functional necessity and category specificity (Lyu et al., 2024).
• Ethics and Fairness Audits: Decomposition of direct, indirect, and spurious disparity pathways supports granular fairness assessments, sub-group heterogeneity detection, and targeted policy (Kohankhaki et al., 2024).
• Policy and Personalized Decision Making: Optimization of individualized policies targeting certain causal pathways (e.g., maximizing a drug's direct chemical effect while neutralizing adherence-driven indirect effects) generalizes dynamic treatment regimes to the pathway-specific setting (Shpitser et al., 2017, Nabi et al., 2018).

6. Challenges and Limitations

Despite substantial progress, rigorous causal pathway analysis faces practical and theoretical barriers.

• Latent Variables and Unmeasured Confounding: Non-identifiability remains an obstruction unless structure, auxiliary proxies, or do-calculus graphical criteria are met (Mohammad-Taheri et al., 2021, Yuan et al., 2023).
• Model Assumptions: Sequential ignorability, exclusion-restriction, absence of exposure-induced mediator-outcome confounding, and faithfulness are routinely untestable and subject to violation in realistic settings (Kundu et al., 1 Jun 2026, Kohankhaki et al., 2024).
• Estimation Efficiency and Consistency: Fluctuation of pointwise convergence rates ($B_j$4 for nuisance ML tasks; nonparametric bias for continuous interventions) impacts inferential validity (McCoy et al., 2023).
• Pathway Selection Instability: High-dimensional contexts and overlapping pathways induce complex selection bias, requiring adaptive weighting, stability selection, or bootstrap aggregation to prioritize plausible pathways (Silver et al., 2012, McCoy et al., 2023).
• Explainability and Falsification: The non-uniqueness and context-dependence of pathway abstractions motivate formal falsification tools and explicit pathway-level explanation scores (Haghighat et al., 29 May 2026).

7. Practical and Computational Frameworks

Deployment of causal pathway methodologies at scale leverages sophisticated computational pipelines, including:

• Automated Causal Structure Discovery: Efficient score-based DAG search (hill-climbing, PCMCI, block coordinate descent for overlapping group lasso) supports real-world data applications (Wei et al., 10 May 2025, Runge, 2015, Silver et al., 2012).
• Pathway Ranking and Prioritization: Bootstrap, permutation, and stability selection deliver empirical confidence in pathway relevance (Silver et al., 2012, Wei et al., 10 May 2025).
• Software Toolchains: Open-source packages (e.g., SuperNOVA for high-dimensional mediation (McCoy et al., 2023), mediation for A/B mediation analysis (Dobra et al., 2019)) and code releases for SCM-based LVM estimation (Mohammad-Taheri et al., 2021) disseminate advanced causal pathway techniques.
• End-to-End Pipelines: Integrated approaches (e.g., multi-omic causal inference (Yazdani et al., 2018), interpretable GNNs for rare-disease pathway identification (Saadat et al., 2024), path-based RAG retrievers for neural LMs (Khadilkar et al., 17 Sep 2025)) exemplify the practical power of the causal pathway paradigm.

Causal pathway analysis thus constitutes a central, technically mature, and continuously developing component of contemporary research in causal inference, computational biology, complex systems, and machine learning, enabling fine-grained mechanistic and policy insight beyond population-average effect estimation.